Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species.
Biochem Pharmacol
; 143: 79-89, 2017 11 01.
Article
en En
| MEDLINE
| ID: mdl-28756208
Palabras clave
1,1,3,3-Tetramethoxypropane (PubChem CID: 66019); 14,15-EET; 2-Thiobarbituric acid (PubChem CID: 2723628); 2',7'-Dichlorofluorescein diacetate (PubChem CID: 101615877); 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (PubChem CID: 64965); 4-Hydroxynonenal (PubChem CID: 5283344); Aldehyde dehydrogenase 1A1; Breast cancer drug resistance; Cell survival; Clotrimazole (PubChem CID: 2812); Cytochrome P450 2J2; Dimethylsulfoxide (PubChem CID: 679); Doxorubicin (PubChem CID: 31703); Malondialdehyde (PubChem CID: 10964); Paclitaxel (PubChem CID: 36314); Reactive oxygen species; Sorafenib (PubChem CID: 216239).; Staurosporine (PubChem CID: 44259)
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Paclitaxel
/
Especies Reactivas de Oxígeno
/
Apoptosis
/
Sistema Enzimático del Citocromo P-450
/
Aldehído Deshidrogenasa
/
Antineoplásicos Fitogénicos
Límite:
Female
/
Humans
Idioma:
En
Revista:
Biochem Pharmacol
Año:
2017
Tipo del documento:
Article
País de afiliación:
Australia